Insider Transactions in Q3 2022 at Cti Biopharma Corp (CTIC)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
139,841
-89.21%
|
$839,046
$6.05 P/Share
|
|
Sep 30
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
139,841
+47.15%
|
$0
$0.95 P/Share
|
|
Sep 29
2022
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
900
-2.55%
|
$5,400
$6.01 P/Share
|
|
Sep 29
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+2.45%
|
$0
$0.95 P/Share
|
|
Sep 16
2022
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,592
-57.19%
|
$135,552
$6.02 P/Share
|
|
Sep 16
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,592
+36.38%
|
$0
$0.95 P/Share
|
|
Sep 12
2022
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
242,300
-89.69%
|
$1,453,800
$6.43 P/Share
|
|
Sep 12
2022
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
242,300
+47.28%
|
$0
$0.84 P/Share
|
|
Aug 16
2022
|
Adam R Craig President and CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+15.22%
|
$25,000
$5.5 P/Share
|
|
Aug 09
2022
|
Bvf Partners L P Director |
BUY
Conversion of derivative security
|
Indirect |
1,519,999
+49.9%
|
-
|
|
Aug 09
2022
|
Bvf Partners L P Director |
SELL
Open market or private sale
|
Indirect |
1,289,434
-99.53%
|
$7,736,604
$6.12 P/Share
|
|
Aug 09
2022
|
Bvf Partners L P Director |
BUY
Conversion of derivative security
|
Direct |
6,863,332
+48.7%
|
-
|
|
Aug 09
2022
|
Bvf Partners L P Director |
SELL
Open market or private sale
|
Direct |
7,210,566
-94.89%
|
$43,263,396
$6.12 P/Share
|
|
Jul 07
2022
|
Michael A Metzger Director |
SELL
Open market or private sale
|
Direct |
20,121
-51.52%
|
$120,726
$6.53 P/Share
|
|
Jul 06
2022
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
18,223
-44.36%
|
$109,338
$6.11 P/Share
|
|
Jul 06
2022
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,223
+30.73%
|
$0
$0.84 P/Share
|
|
Jul 05
2022
|
Michael A Metzger Director |
SELL
Open market or private sale
|
Direct |
91,500
-31.62%
|
$549,000
$6.1 P/Share
|
|
Jul 05
2022
|
Michael A Metzger Director |
BUY
Exercise of conversion of derivative security
|
Direct |
91,500
+45.05%
|
$0
$0.84 P/Share
|
|
Jul 05
2022
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-54.15%
|
$162,000
$6.0 P/Share
|
|
Jul 05
2022
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+35.13%
|
$0
$0.84 P/Share
|
|
Jul 01
2022
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
27,000
-54.15%
|
$162,000
$6.0 P/Share
|
|
Jul 01
2022
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+35.13%
|
$0
$0.84 P/Share
|